💾 Archived View for gmi.noulin.net › mobileNews › 2285.gmi captured on 2023-01-29 at 07:31:49. Gemini links have been rewritten to link to archived content

View Raw

More Information

⬅️ Previous capture (2021-12-03)

➡️ Next capture (2024-05-10)

🚧 View Differences

-=-=-=-=-=-=-

Vitamin B 'puts off Alzheimer's'

2010-09-09 12:11:34

By Jane Hughes Health correspondent, BBC News

CT scan Brain scan of a person with Alzheimer's

A new study suggests high doses of B vitamins may halve the rate of brain

shrinkage in older people experiencing some of the warning signs of Alzheimer's

disease.

Brain shrinkage is one of the symptoms of mild cognitive impairment, which

often leads to dementia.

Researchers say this could be the first step towards finding a way to delay the

onset of Alzheimer's.

Experts said the findings were important but more research was needed.

The study, published in the journal Public Library of Science One, looked at

168 elderly people experiencing levels of mental decline known as mild

cognitive impairment.

This condition, marked by mild memory lapses and language problems, is beyond

what can be explained by normal ageing and can be a precursor to Alzheimer's

and other forms of dementia.

Half of the volunteers were given a daily tablet containing levels of the B

vitamins folate, B6 and B12 well above the recommended daily amount. The other

half were given a placebo.

After two years, the rate at which their brains had shrunk was measured.

The average brain shrinks at a rate of 0.5% a year after the age of 60. The

brains of those with mild cognitive impairment shrink twice as fast.

Alzheimer's patients have brain shrinkage of 2.5% a year.

The team, from the Oxford Project to investigate Memory and Ageing (Optima),

found that on average, in those taking vitamin supplements, brain shrinkage

slowed by 30%.

In some cases it slowed by more than 50%, making their brain atrophy no worse

than that of people without cognitive impairment.

'Protecting' the brain

Certain B vitamins - folic acid, vitamin B6 and B12 - control levels of a

substance known as homocysteine in the blood. High levels of homocysteine are

associated with faster brain shrinkage and Alzheimer's disease.

Continue reading the main story

Start Quote

These vitamins are doing something to the brain structure - they're protecting

it, and that's very important because we need to protect the brain to prevent

Alzheimer's

End Quote Professor David Smith Oxford University

The study authors believe it was the B vitamins' effect on levels of

homocysteine that helped slow the rate of brain shrinkage.

The study author, Professor David Smith, said the results were more significant

than he had expected.

"It's a bigger effect than anyone could have predicted," he said, "and it's

telling us something biological.

"These vitamins are doing something to the brain structure - they're protecting

it, and that's very important because we need to protect the brain to prevent

Alzheimer's."

He said more research was now needed to see whether high doses of B vitamins

actually prevented the development of Alzheimer's in people with mild cognitive

impairment.

The Alzheimer's Research Trust, which co-funded the study, also called for

further investigation.

"These are very important results, with B vitamins now showing a prospect of

protecting some people from Alzheimer's in old age," said chief executive

Rebecca Wood.

"The strong findings must inspire an expanded trial to follow people expected

to develop Alzheimer's."

B vitamins are found naturally in many foods, including meat, fish, eggs and

green vegetables.

Experts are advising against taking higher than recommended levels in the light

of these findings.

Chris Kennard, chair of the Medical Research Council's Neurosciences and Mental

Health Board, said: "We must be cautious when recommending supplements like

vitamin B as there are separate health risks if taken in too high doses.

"Further research is required before we can recommend the supplement as a

treatment for neurodegenerative diseases, such as Alzheimer's."